Chemotherapy: What Progress in the Last 5 Years?

This publication has 96 references indexed in Scilit:

• Chemotherapy or Combined Modality Treatment: The Optimal Treatment for Hodgkin's Disease
  Journal of Clinical Oncology, 2004
• The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
  Journal of Clinical Oncology, 2003
• Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
  Journal of Clinical Oncology, 2003
• National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
  JNCI Journal of the National Cancer Institute, 2001
• An eight weeks dose-dense versus a 24 weeks sequential adriamcycin/docetaxel combination as preoperative chemotherapy (CHT) in operable breast cancer (T2-3, N0-2,M0)
  European Journal Of Cancer, 2001
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II study
  Breast Cancer Research and Treatment, 1996
• Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
  Cancer, 1994
• Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More
  JNCI Journal of the National Cancer Institute, 1990
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988